Deerfield
About Deerfield

Launched in 1994, Deerfield Management Company is an investment firm dedicated to advancing healthcare through information, investment, and philanthropy—all toward the end goal of cures for disease, improved quality of life, and reduced cost of care.

Read More
---
Investment

Supporting companies across the healthcare ecosystem with flexible funding models…

Read More
---
Information

Delivering market research to the Deerfield team, its portfolio companies and other partners.

Read More ---
Philanthropy

A New York City-based not-for-profit devoted to advancing innovative health care initiatives.

Read More
---
Portfolio Companies

Deerfield generally maintains a combined portfolio of more than 150 private and public investments across the life science, medical device, diagnostic, digital health and health service industries at all stages of evolution from start-up to mature company.

Read More View Portfolio Companies
---
Research Collaborations

Deerfield partners with leading academic research centers, providing critical funding and expertise to further sustain and accelerate the commercialization of discoveries toward meaningful societal impact by advancing cures for disease.

Read More View Research Collaborations
---
Strategic Partners

As a strategic partner, Deerfield offers capital, scientific expertise, business operating support, and unique access to innovation.

Read More
---
Deerfield Foundation

The Deerfield Foundation is a New York City-based not-for-profit organization whose mission is to improve health, accelerate innovation and promote human equity.

Read More Meet the Foundation Team
---
Cure Campus

Cure is a 12-story innovations campus in New York City that intends to bring together innovators from academia, government, industry, and the not-for-profit sectors to advance human health and accelerate the fight against disease.

Read More Join the Cure Email List
Cure Programming

Cure has a series of expert lectures intended to advance thought in healthcare, management, innovation, policy, and other relevant subjects. This fosters growth and education for those at Cure and its guests.

Events at the Cure

Deerfield Offers Expanded Access to Innovation, Expertise and Resources

Select Industry Partnerships

Deerfield partners with healthcare companies and research institutions working on new discoveries across the spectrum of healthcare. Access to innovation comes through Deerfield’s research collaboration network consisting of leading institutions in innovation and research, medical technology incubators and internal expertise. We help our partners achieve their development and commercialization goals faster, more efficiently, and with measurable impact. Specialized teams at Deerfield assess commercial viability, conduct market research, and provide experts with deep skillsets across the entire R&D continuum.

Deerfield’s CURE, an innovation ecosystem, offers our strategic partners unique access to specialized equipment, expertise development, and access to talent and innovation as a resident or as a collaborator.

Invitae

For informational purposes only, as of 4/5/2023


Deerfield Discovery & Development

Deerfield Discovery and Development (3DC) team at Deerfield provides strategic partners with deep functional expertise and experience across key disciplines and plays a critical role in progressing early stage therapeutics from scientific discovery through preclinical proof of concept and into the clinic.


Genscience | Human Genetic Foresight

Genscience integrates world-class genetic insights into drug discovery and development decisions with differentiated expertise, platforms, and analytics.


Research Collaborations

Baylor College of Medicine
Blue Square Discoveries
Beth Israel Deaconess Medical Center
Brookline Avenue Innovations
Boston Children’s Hospital
Blackfan Circle Innovations
Broad Institute
Broad Institute
Cold Spring Harbor Laboratory
Harbor Discoveries
Columbia University
Hudson Heights Innovations
Dana-Farber Cancer Institute
Riverway Discoveries
Dana-Farber Cancer Institute
The Center for Protein Degradation
Duke University
Four Points Innovation
Empire Discovery Institute
Empire Deerfield Discovery and Development
Harvard University
Lab1636
MD Anderson Cancer Center
Vescor Therapeutics
Memorial Sloan Kettering Cancer Center, Rockefeller University, Weill Cornell Medicine
Bridge Medicines
Moffitt Cancer Center
Bayfield Therapeutics
Northwestern University
Lakeside Discovery
NYU Langone Health
Amethyst Innovations 
Stanford University
Porter Alliance for Innovative Medicines
The Johns Hopkins University
Bluefield Innovations
University of California San Diego
Poseidon Innovation
University of Illinois at Chicago
West Loop Innovations
University of Michigan
Great Lakes Discovery
University of North Carolina at Chapel Hill
Pinnacle Hill
Vanderbilt University
Ancora Innovation
Washington University in St. Louis
VeritaScience
Yeda | Weizmann Institute of Science
Orchard Innovations

The Deerfield Institute

The Deerfield Institute, a division of Deerfield, delivers sophisticated and timely market research, which enhances the insights to the investment team and its partners. The Institute develops and analyzes data to advance understanding of innovations and emerging products, and it also informs on trends within the healthcare market. The Institute is guided by Deerfield’s core values: integrity, the pursuit of objective and unbiased research, commitment to excellence, precision and accuracy.


Contact Us

Karen Heidelberger

Partner, Chief Partnership and Communications Officer
917.592.1388
[email protected]